Search results

Cardiac Health - Richmond Research Institute
www.richmondresearchinstitute.org/research/cardiac-health

Cardiac Health. Clinical Trial Design & Methodology. Hepatology. Ethnic and Sex Differences Physiology & Drug Responses. Publications. News. Careers. Support. Contact. Cardiac Health.

Professor Giuseppe Rosano - Scientific Lead – Cardiac Health: Sex
www.richmondresearchinstitute.org/scientific-team/professor-giuseppe-rosano

Cardiac Health. Clinical Trial Design & Methodology. Hepatology. Ethnic and Sex Differences Physiology & Drug Responses. Publications. News. Careers. Support. Contact. Professor Giuseppe Rosano. Scientific Lead – Cardiac Health, Sex.

Dr. Boaz Mendzelevski - Cardiac Safety and Electrocardiography Scientific Lead
www.richmondresearchinstitute.org/scientific-team/dr-boaz-mendzelevski

Cardiac Health. Clinical Trial Design & Methodology. Hepatology. Ethnic and Sex Differences Physiology & Drug Responses. Publications. News. Careers. Support. Contact. Dr Boaz Mendzelevski. Scientific Lead - Cardiac Health, Electrocardiography. Dr.

Phase I study confirms cardiac safety of potential alopecia treatment
www.richmondresearchinstitute.org/news/phase-i-study-confirms-cardiac-safety-of-potential-alopecia-treatment

Phase I study confirms cardiac safety of potential alopecia treatment. Cardiac. Phase I. 19th May 2021. Clinical trials of potential new medicines must demonstrate cardiac safety.

News - Richmond Research Institute
www.richmondresearchinstitute.org/news

Cardiac. Diabetes. RRI study finds antimalaria drug has no negative impact on cardiac safety in healthy volunteers.

Cardiac safety of nolasiban confirmed in Phase I clinical trial
www.richmondresearchinstitute.org/news/cardiac-safety-of-nolasiban-confirmed-in-phase-i-clinical-trial

Cardiac safety of nolasiban confirmed in Phase I clinical trial. Cardiac. Phase I. 5th May 2021.

Why more caution is needed in administering QT prolonging drugs to type 1 diabetic patients.
www.richmondresearchinstitute.org/news/why-more-caution-is-needed-in-administering-qt-prolonging-drugs-to-type-1-diabetic-patients

Cardiac ion channel blockers.

Dr Dominic Pimenta wins the 'Young Investigators Award for Primary Care and Risk Factor Management'
www.richmondresearchinstitute.org/news/dr-dominic-pimenta-wins-the-young-investigators-award-for-primary-care-and-risk-factor-management

RRI study finds antimalaria drug has no negative impact on cardiac safety in healthy volunteers. Cardiac. Clinical Trial Design & Methodology.

RRI study finds antimalaria drug has no negative impact on cardiac safety in healthy volunteers
www.richmondresearchinstitute.org/news/rri-study-finds-antimalaria-drug-has-no-negative-impact-on-cardiac-safety-in-healthy-volunteers

RRI study finds antimalaria drug has no negative impact on cardiac safety in healthy volunteers. Cardiac. Clinical Trial Design & Methodology. 10th August 2021. What is malaria? Malaria is a life-threatening infection caused by the Plasmodium parasite.

Why patient safety is paramount in patient trials
www.richmondresearchinstitute.org/news/dr-jorg-taubel-stresses-why-patient-safety-is-paramount-in-patient-trials

Cardiac Health. Clinical Trial Design & Methodology. Hepatology. Ethnic and Sex Differences Physiology & Drug Responses. Publications. News. Careers. Support. Contact. What’s a Rich Text element? (H1).

We work with partners at the following organisations: 

richmond research institute

We have a track record in conducting clinical research.

Publications

We present our scientific findings at meetings.

Videos

Our academic research helps improve lives and strengthens scientific insights.

Research